{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18250191", "DateCompleted": {"Year": "2008", "Month": "03", "Day": "17"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1084/jem.20071507"], "ArticleDate": [{"Year": "2008", "Month": "02", "Day": "04"}], "Journal": {"ISSN": "1540-9538", "JournalIssue": {"Volume": "205", "Issue": "2", "PubDate": {"Year": "2008", "Month": "Feb", "Day": "18"}}, "Title": "The Journal of experimental medicine", "ISOAbbreviation": "J Exp Med"}, "ArticleTitle": "Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17.", "Pagination": {"StartPage": "385", "EndPage": "393", "MedlinePgn": "385-93"}, "Abstract": {"AbstractText": ["Exposure to ozone, which is a major component of air pollution, induces a form of asthma that occurs in the absence of adaptive immunity. Although ozone-induced asthma is characterized by airway neutrophilia, and not eosinophilia, it is nevertheless associated with airway hyperreactivity (AHR), which is a cardinal feature of asthma. Because AHR induced by allergens requires the presence of natural killer T (NKT) cells, we asked whether ozone-induced AHR had similar requirements. We found that repeated exposure of wild-type (WT) mice to ozone induced severe AHR associated with an increase in airway NKT cells, neutrophils, and macrophages. Surprisingly, NKT cell-deficient (CD1d(-/-) and Jalpha18(-/-)) mice failed to develop ozone-induced AHR. Further, treatment of WT mice with an anti-CD1d mAb blocked NKT cell activation and prevented ozone-induced AHR. Moreover, ozone-induced, but not allergen-induced, AHR was associated with NKT cells producing interleukin (IL)-17, and failed to occur in IL-17(-/-) mice nor in WT mice treated with anti-IL-17 mAb. Thus, ozone exposure induces AHR that requires the presence of NKT cells and IL-17 production. Because NKT cells are required for the development of two very disparate forms of AHR (ozone- and allergen-induced), our results strongly suggest that NKT cells mediate a unifying pathogenic mechanism for several distinct forms of asthma, and represent a unique target for effective asthma therapy."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA."}], "Identifier": [], "LastName": "Pichavant", "ForeName": "Muriel", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Goya", "ForeName": "Sho", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Meyer", "ForeName": "Everett H", "Initials": "EH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Johnston", "ForeName": "Richard A", "Initials": "RA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Hye Y", "Initials": "HY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Matangkasombut", "ForeName": "Ponpan", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhu", "ForeName": "Ming", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Iwakura", "ForeName": "Yoichiro", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Savage", "ForeName": "Paul B", "Initials": "PB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "DeKruyff", "ForeName": "Rosemarie H", "Initials": "RH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shore", "ForeName": "Stephanie A", "Initials": "SA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Umetsu", "ForeName": "Dale T", "Initials": "DT"}], "GrantList": [{"GrantID": "T32 AI007290", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "HL062348", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL062348", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P01 AI054456", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "AI054456", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Exp Med", "NlmUniqueID": "2985109R", "ISSNLinking": "0022-1007"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-13"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-17"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9006-59-1", "NameOfSubstance": "Ovalbumin"}], "MeshHeadingList": [{"QualifierName": ["toxicity"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "immunology"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": ["cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["deficiency", "genetics", "immunology"], "DescriptorName": "Interleukin-13"}, {"QualifierName": ["deficiency", "genetics", "immunology"], "DescriptorName": "Interleukin-17"}, {"QualifierName": ["deficiency", "genetics", "immunology"], "DescriptorName": "Interleukin-4"}, {"QualifierName": ["immunology"], "DescriptorName": "Killer Cells, Natural"}, {"QualifierName": [], "DescriptorName": "Leukocyte Count"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Ovalbumin"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["immunology"], "DescriptorName": "T-Lymphocytes"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gold, D.R., and R. Wright. 2005. Population disparities in asthma. Annu. Rev. Public Health. 26:89\u2013113.", "ArticleIdList": ["15760282"]}, {"Citation": "Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255\u2013281.", "ArticleIdList": ["10358759"]}, {"Citation": "Voehringer, D., T.A. Reese, X. Huang, K. Shinkai, and R.M. Locksley. 2006. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J. Exp. Med. 203:1435\u20131446.", "ArticleIdList": ["PMC2118302", "16702603"]}, {"Citation": "Gibson, P.G., J.L. Simpson, and N. Saltos. 2001. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 119:1329\u20131336.", "ArticleIdList": ["11348936"]}, {"Citation": "Li, N., J. Alam, M.I. Venkatesan, A. Eiguren-Fernandez, D. Schmitz, E. Di Stefano, N. Slaughter, E. Killeen, X. Wang, A. Huang, et al. 2004. Nrf 2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J. Immunol. 173:3467\u20133481.", "ArticleIdList": ["15322212"]}, {"Citation": "Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23:877\u2013900.", "ArticleIdList": ["15771592"]}, {"Citation": "Brutkiewicz, R.R. 2006. CD1d ligands: the good, the bad, and the ugly. J. Immunol. 177:769\u2013775.", "ArticleIdList": ["16818729"]}, {"Citation": "Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557\u2013568.", "ArticleIdList": ["12154375"]}, {"Citation": "Park, S.H., K. Benlagha, D. Lee, E. Balish, and A. Bendelac. 2000. Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice. Eur. J. Immunol. 30:620\u2013625.", "ArticleIdList": ["10671219"]}, {"Citation": "Bendelac, A., P.B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297\u2013336.", "ArticleIdList": ["17150027"]}, {"Citation": "Mercer, J.C., M.J. Ragin, and A. August. 2005. Natural killer T cells: rapid responders controlling immunity and disease. Int. J. Biochem. Cell Biol. 37:1337\u20131343.", "ArticleIdList": ["15833265"]}, {"Citation": "Nieuwenhuis, E.E., T. Matsumoto, M. Exley, R.A. Schleipman, J. Glickman, D.T. Bailey, N. Corazza, S.P. Colgan, A.B. Onderdonk, and R.S. Blumberg. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8:588\u2013593.", "ArticleIdList": ["12042809"]}, {"Citation": "Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:582\u2013588.", "ArticleIdList": ["12669034"]}, {"Citation": "Lisbonne, M., S. Diem, A. de Castro Keller, J. Lefort, L.M. Araujo, P. Hachem, J.M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, et al. 2003. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171:1637\u20131641.", "ArticleIdList": ["12902459"]}, {"Citation": "Smiley, S.T., M.H. Kaplan, and M.J. Grusby. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science. 275:977\u2013979.", "ArticleIdList": ["9020080"]}, {"Citation": "Meyer, E.H., S. Goya, O. Akbari, G.J. Berry, P.B. Savage, M. Kronenberg, T. Nakayama, R.H. DeKruyff, and D.T. Umetsu. 2006. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci. USA. 103:2782\u20132787.", "ArticleIdList": ["PMC1413796", "16478801"]}, {"Citation": "Akbari, O., J.L. Faul, E.G. Hoyte, G.J. Berry, J. Wahlstrom, M. Kronenberg, R.H. DeKruyff, and D.T. Umetsu. 2006. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354:1117\u20131129.", "ArticleIdList": ["16540612"]}, {"Citation": "Hamzaoui, A., S.C. Rouhou, H. Grairi, H. Abid, J. Ammar, H. Chelbi, and K. Hamzaoui. 2006. NKT cells in the induced sputum of severe asthmatics. Mediators Inflamm. 2006:71214.", "ArticleIdList": ["PMC1592585", "16883065"]}, {"Citation": "Sen, Y., B. Yongyi, H. Yuling, X. Luokun, H. Li, X. Jie, D. Tao, Z. Gang, L. Junyan, H. Chunsong, et al. 2005. V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J. Immunol. 175:4914\u20134926.", "ArticleIdList": ["16210593"]}, {"Citation": "Gent, J.F., E.W. Triche, T.R. Holford, K. Belanger, M.B. Bracken, W.S. Beckett, and B.P. Leaderer. 2003. Association of low-level ozone and fine particles with respiratory symptoms in children with asthma. JAMA. 290:1859\u20131867.", "ArticleIdList": ["14532314"]}, {"Citation": "Babin, S.M., H.S. Burkom, R.S. Holtry, N.R. Tabernero, L.D. Stokes, J.O. Davies-Cole, K. DeHaan, and D.H. Lee. 2007. Pediatric patient asthma-related emergency department visits and admissions in Washington, DC, from 2001-2004, and associations with air quality, socio-economic status and age group. Environ. Health. 6:9.", "ArticleIdList": ["PMC1845147", "17376237"]}, {"Citation": "Tolbert, P.E., J.A. Mulholland, D.L. MacIntosh, F. Xu, D. Daniels, O.J. Devine, B.P. Carlin, M. Klein, J. Dorley, A.J. Butler, et al. 2000. Air quality and pediatric emergency room visits for asthma in Atlanta, Georgia, USA. Am. J. Epidemiol. 151:798\u2013810.", "ArticleIdList": ["10965977"]}, {"Citation": "Aris, R.M., D. Christian, P.Q. Hearne, K. Kerr, W.E. Finkbeiner, and J.R. Balmes. 1993. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am. Rev. Respir. Dis. 148:1363\u20131372.", "ArticleIdList": ["8239177"]}, {"Citation": "Devlin, R.B., W.F. McDonnell, R. Mann, S. Becker, D.E. House, D. Schreinemachers, and H.S. Koren. 1991. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am. J. Respir. Cell Mol. Biol. 4:72\u201381.", "ArticleIdList": ["1846079"]}, {"Citation": "Bayram, H., R.J. Sapsford, M.M. Abdelaziz, and O.A. Khair. 2001. Effect of ozone and nitrogen dioxide on the release of proinflammatory mediators from bronchial epithelial cells of nonatopic nonasthmatic subjects and atopic asthmatic patients in vitro. J. Allergy Clin. Immunol. 107:287\u2013294.", "ArticleIdList": ["11174195"]}, {"Citation": "Ferretti, S., O. Bonneau, G.R. Dubois, C.E. Jones, and A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170:2106\u20132112.", "ArticleIdList": ["12574382"]}, {"Citation": "Miyamoto, M., O. Prause, M. Sjostrand, M. Laan, J. Lotvall, and A. Linden. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170:4665\u20134672.", "ArticleIdList": ["12707345"]}, {"Citation": "Cho, H.Y., L.Y. Zhang, and S.R. Kleeberger. 2001. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L537\u2013L546.", "ArticleIdList": ["11159038"]}, {"Citation": "Johnston, R.A., I.N. Schwartzman, L. Flynt, and S.A. Shore. 2005. Role of interleukin-6 in murine airway responses to ozone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:L390\u2013L397.", "ArticleIdList": ["15516495"]}, {"Citation": "Park, J.W., C. Taube, C. Swasey, T. Kodama, A. Joetham, A. Balhorn, K. Takeda, N. Miyahara, C.B. Allen, A. Dakhama, et al. 2004. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am. J. Respir. Cell Mol. Biol. 30:830\u2013836.", "ArticleIdList": ["14754758"]}, {"Citation": "Shore, S.A., I.N. Schwartzman, B. Le Blanc, G.G. Murthy, and C.M. Doerschuk. 2001. Tumor necrosis factor receptor 2 contributes to ozone-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 164:602\u2013607.", "ArticleIdList": ["11520723"]}, {"Citation": "Yu, M., X. Zheng, H. Witschi, and K.E. Pinkerton. 2002. The role of interleukin-6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Toxicol. Sci. 68:488\u2013497.", "ArticleIdList": ["12151646"]}, {"Citation": "Todokoro, M., H. Mochizuki, K. Tokuyama, M. Utsugi, K. Dobashi, M. Mori, and A. Morikawa. 2004. Effect of ozone exposure on intracellular glutathione redox state in cultured human airway epithelial cells. Inflammation. 28:105\u2013114.", "ArticleIdList": ["15379216"]}, {"Citation": "Romieu, I., M. Ramirez-Aguilar, J.J. Sienra-Monge, H. Moreno-Macias, B.E. del Rio-Navarro, G. David, J. Marzec, M. Hernandez-Avila, and S. London. 2006. GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur. Respir. J. 28:953\u2013959.", "ArticleIdList": ["16870661"]}, {"Citation": "Rangasamy, T., J. Guo, W.A. Mitzner, J. Roman, A. Singh, A.D. Fryer, M. Yamamoto, T.W. Kensler, R.M. Tuder, S.N. Georas, and S. Biswal. 2005. Disruption of Nrf 2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 202:47\u201359.", "ArticleIdList": ["PMC2212893", "15998787"]}, {"Citation": "Ivanov, I.I., B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J. Lafaille, D.J. Cua, and D.R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126:1121\u20131133.", "ArticleIdList": ["16990136"]}, {"Citation": "Michel, M.L., A.C. Keller, C. Paget, M. Fujio, F. Trottein, P.B. Savage, C.H. Wong, E. Schneider, M. Dy, and M.C. Leite-de-Moraes. 2007. Identification of an IL-17\u2013producing NK1.1neg iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204:995\u20131001.", "ArticleIdList": ["PMC2118594", "17470641"]}, {"Citation": "Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 17:375\u2013387.", "ArticleIdList": ["12354389"]}, {"Citation": "Linden, A., M. Laan, and G.P. Anderson. 2005. Neutrophils, interleukin-17A and lung disease. Eur. Respir. J. 25:159\u2013172.", "ArticleIdList": ["15640338"]}, {"Citation": "Bullens, D.M., E. Truyen, L. Coteur, E. Dilissen, P.W. Hellings, L.J. Dupont, and J.L. Ceuppens. 2006. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7:135.", "ArticleIdList": ["PMC1636037", "17083726"]}, {"Citation": "Kawaguchi, M., D. Takahashi, N. Hizawa, S. Suzuki, S. Matsukura, F. Kokubu, Y. Maeda, Y. Fukui, S. Konno, S.K. Huang, et al. 2006. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J. Allergy Clin. Immunol. 117:795\u2013801.", "ArticleIdList": ["16630936"]}, {"Citation": "Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Page, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108:430\u2013438.", "ArticleIdList": ["11544464"]}, {"Citation": "Hellings, P.W., A. Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, and J.L. Ceuppens. 2003. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28:42\u201350.", "ArticleIdList": ["12495931"]}, {"Citation": "Schnyder-Candrian, S., D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, and B. Schnyder. 2006. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203:2715\u20132725.", "ArticleIdList": ["PMC2118159", "17101734"]}, {"Citation": "D'Amato, G., G. Liccardi, M. D'Amato, and S. Holgate. 2005. Environmental risk factors and allergic bronchial asthma. Clin. Exp. Allergy. 35:1113\u20131124.", "ArticleIdList": ["16164436"]}, {"Citation": "Nel, A. 2005. Atmosphere. Air pollution-related illness: effects of particles. Science. 308:804\u2013806.", "ArticleIdList": ["15879201"]}, {"Citation": "VanderLaan, P.A., C.A. Reardon, Y. Sagiv, L. Blachowicz, J. Lukens, M. Nissenbaum, C.R. Wang, and G.S. Getz. 2007. Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. Am. J. Pathol. 170:1100\u20131107.", "ArticleIdList": ["PMC1864866", "17322392"]}, {"Citation": "Ronmark, E., C. Andersson, L. Nystrom, B. Forsberg, B. Jarvholm, and B. Lundback. 2005. Obesity increases the risk of incident asthma among adults. Eur. Respir. J. 25:282\u2013288.", "ArticleIdList": ["15684292"]}, {"Citation": "Lu, F.L., R.A. Johnston, L. Flynt, T.A. Theman, R.D. Terry, I.N. Schwartzman, A. Lee, and S.A. Shore. 2006. Increased pulmonary responses to acute ozone exposure in obese db/db mice. Am. J. Physiol. 290:L856\u2013L865.", "ArticleIdList": ["16373670"]}, {"Citation": "Behar, S.M., C.C. Dascher, M.J. Grusby, C.R. Wang, and M.B. Brenner. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189:1973\u20131980.", "ArticleIdList": ["PMC2192974", "10377193"]}, {"Citation": "Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623\u20131626.", "ArticleIdList": ["9374462"]}, {"Citation": "Shore, S.A., R.A. Johnston, I.N. Schwartzman, D. Chism, and G.G. Krishna Murthy. 2002. Ozone-induced airway hyperresponsiveness is reduced in immature mice. J. Appl. Physiol. 92:1019\u20131028.", "ArticleIdList": ["11842035"]}]}], "History": [{"Year": "2008", "Month": "2", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "3", "Day": "18", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "2", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "8", "Day": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18250191", "PMC2271004", "10.1084/jem.20071507", "jem.20071507"]}}], "PubmedBookArticle": []}